There is no cure for shingles. The virus that causes it, varicella-zoster, hides inside nerve cells in a dormant form that no current medication can eliminate. Once you’ve had chickenpox, the virus stays in your body for life. What medicine can do is shorten an outbreak, reduce pain, and lower the chance of lingering complications. Prevention through vaccination is currently the most effective strategy available.
Why the Virus Can’t Be Eliminated
After a childhood chickenpox infection, varicella-zoster virus retreats into clusters of nerve cells along the spine and skull called ganglia. There, it parks its genetic material in a circular loop inside the nucleus of neurons and goes mostly silent, with only a tiny region of its DNA still active. This dormant state is called latency, and it’s a survival trick shared by all human herpes viruses.
The problem for medicine is that latent virus isn’t replicating. Antiviral drugs work by disrupting viral replication, so they have no target when the virus is quietly sitting inside a nerve cell. The virus also doesn’t display the usual surface markers that would flag it for destruction by your immune system. Because chickenpox typically occurs so early in life, latency is established long before any intervention could prevent it. Current research is focused not on clearing the virus entirely but on finding ways to prevent it from reactivating.
What Antiviral Treatment Actually Does
When shingles reactivates, antiviral medications can speed up rash healing and limit the severity and duration of pain. Treatment works best when started within 72 hours of the rash appearing, though that cutoff comes from how clinical trials were designed rather than a hard biological deadline. Roughly 65% of adults see a doctor within that 72-hour window.
Antivirals are typically prescribed as a seven-day course of oral medication. There is also evidence that early treatment reduces the risk of postherpetic neuralgia, the chronic nerve pain that can follow shingles, likely by limiting the amount of damage the virus does to nerve tissue during reactivation. Antivirals won’t kill the dormant virus or prevent future outbreaks. They only fight the virus while it’s actively replicating during a flare.
The Typical Shingles Timeline
Shingles follows a fairly predictable pattern. It starts with skin sensitivity, tingling, itching, or pain in a band-like area on one side of the body, sometimes days before anything is visible. A rash appears one to five days after those initial sensations. Blisters form, fill with fluid, then scab over within 7 to 10 days. Complete skin healing takes two to four weeks, and the full episode usually resolves within three to five weeks.
For most people, shingles is a one-time event. But the overall recurrence rate is about 5.3%, or 12 per 1,000 people per year. Among those who do experience a second episode, the vast majority (82%) have normal immune systems, so recurrence isn’t limited to people with weakened immunity. A small number of people experience a third outbreak.
Postherpetic Neuralgia: The Main Complication
The complication most people worry about is postherpetic neuralgia (PHN), a burning or stabbing pain that persists in the area of the rash for three months or longer after the initial outbreak. About 13% of shingles patients aged 50 and older develop it. The risk climbs steeply with age: around 60% of shingles patients at age 60 and 75% at age 70 experience some degree of PHN.
At one month after shingles onset, 9 to 14% of patients have PHN-level pain. By three months, that drops to about 5%. At one year, 3% still have severe pain. The sensation can include burning, electric-shock-like jolts, intense sensitivity to light touch (where even clothing brushing the skin is painful), and persistent itching or tingling.
PHN is managed with medications that calm overactive nerve signaling. The two FDA-approved options work by binding to calcium channels in neurons, dialing down the transmission of pain signals. Doctors typically start at a lower dose and increase over three to eight weeks until pain is controlled. Older antidepressant medications that affect nerve pain pathways are also used. For localized pain, a high-concentration capsaicin patch (derived from hot peppers) can be applied for 60 minutes in a clinic setting. It initially triggers intense burning, then desensitizes the pain-transmitting nerve endings in the skin. Treatments can be repeated every 90 days. Opioids are sometimes used but remain controversial for PHN because of the risk of dependence and side effects.
Shingles Near the Eye
When shingles affects the nerve branch that serves the forehead and eye (a condition called herpes zoster ophthalmicus), the stakes are higher. About half of people with this form develop eye involvement, and up to 25% of those go on to have chronic or recurrent eye disease. Complications range from inflammation of the cornea and inner eye structures to, in rare cases, vision loss. A rash extending to the tip of the nose is a warning sign of eye involvement because that skin shares nerve supply with the eye itself. Any vision changes, eye pain, or sensitivity to light during a shingles episode affecting the face warrants prompt evaluation by an eye specialist.
Vaccination Is the Closest Thing to Prevention
Since the virus can’t be removed from the body, preventing reactivation is the next best option. The recombinant shingles vaccine, given as two doses, is about 74% effective at preventing a shingles episode in adults 50 and older, based on real-world data from a large U.S. study. Its protection against postherpetic neuralgia is even stronger, at roughly 84%. A single dose provides about 60% protection against shingles, so completing the two-dose series matters.
The vaccine works by boosting the immune system’s ability to keep the dormant virus in check. It doesn’t eliminate the virus from nerve cells, but a stronger immune response makes reactivation far less likely. Adults 50 and older are recommended to get vaccinated regardless of whether they remember having chickenpox, since over 99% of Americans born before 1980 carry the virus.